1. |
Sonnenberg A. Hospitalization for achalasia in the United States 1997-2006. Dig Dis Sci, 2009, 54(8): 1680-1685.
|
2. |
Wen ZH, Gardener E, Wang YP.Nitrates for achalasia. Cochrane Database Syst Rev, 2004(1): CD002299.
|
3. |
Nasrallah SM, Tommaso CL, Singleton RT, et al. Primary esophageal motor disorders: clinical response to nifedipine. South Med J, 1985, 78(3): 312-315.
|
4. |
Traube M, Dubovik S, Lange RC, et al. The role of nifedipine therapy in achalasia: results of a randomized, double-blind, placebo-controlled study. Am J Gastroenterol, 1989, 84(10): 1259-1562.
|
5. |
Bortolotti M, Mari C, Lopilato C, et al. Effects of sildenafil on esophageal motility of patients with idiopathic achalasia. Gastroenterology, 2000, 118(2): 253-257.
|
6. |
Pasricha PJ, Ravich WJ, Hendrix TR, et al. Intrasphincteric botulinum toxin for the treatment of achalasia. N Engl J Med, 1995, 332(12): 774-778.
|
7. |
Kolbasnik J, Waterfall WE, Fachnie B, et al. Long-term efficacy of Botulinum toxin in classical achalasia: a prospective study. Am J Gastroenterol, 1999, 94(12): 3434-3439.
|
8. |
D’Onofrio V, Annese V, Miletto P, et al. Long-term follow-up of achalasia patients treated with botulinum toxin. Dig Liver Dis, 2002, 34(2): 105-110.
|
9. |
Muehldorfer SM, Hahn EG, Ell C. High- and low-compliance balloon dilators in patients with achalasia: a randomized prospective comparative trial. Gastrointest Endosc, 1996, 44(4): 398-403.
|
10. |
Gideon RM, Castell DO, Yarze J. Prospective randomized comparison of pneumatic dilatation technique in patients with idiopathic achalasia. Dig Dis Sci, 1999, 44(9): 1853-1857.
|
11. |
Mikaeli J, Fazel A, Montazeri G, et al. Randomized controlled trial comparing botulinum toxin injection to pneumatic dilatation for the treatment of achalasia. Aliment Pharmacol Ther, 2001, 15(9): 1389-1396.
|
12. |
Falkenback D, Johansson J, Oberg S, et al. Heller’s esophagomyotomy with or without a 360 degrees floppy Nissen fundoplication for achalasia. Long-term results from a prospective randomized study. Dis Esophagus, 2003. 16(4): 284-290.
|
13. |
Richards WO, Torquati A, Holzman MD, et al. Heller myotomy versus Heller myotomy with Dor fundoplication for achalasia: a prospective randomized double-blind clinical trial. Ann Surg, 2004, 240(3): 405-412; discussion 412-415.
|
14. |
Ramacciato G, Mercantini P, Amodio PM, et al. The laparoscopic approach with antireflux surgery is superior to the thoracoscopic approach for the treatment of esophageal achalasia. Experience of a single surgical unit. Surg Endosc, 2002, 16(10): 1431-1437.
|
15. |
Patti MG, Arcerito M, De Pinto M, et al. Comparison of thoracoscopic and laparoscopic Heller myotomy for achalasia. J Gastrointest Surg, 1998, 2(6): 561-566.
|
16. |
Mikaeli J, Yaghoobi M, Montazeri G, et al. Efficacy of botulinum toxin injection before pneumatic dilatation in patients with idiopathic achalasia. Dis Esophagus, 2004, 17(3): 213-217.
|
17. |
Campos GM, Vittinghoff E, Rabl C, et al. Endoscopic and surgical treatments for achalasia: a systematic review and meta-analysis. Ann Surg, 2009, 249(1): 45-57.
|
18. |
Wang L, Li YM, Li L. Meta-analysis of randomized and controlled treatment trials for achalasia. Dig Dis Sci, 2009, 54(11): 2303-2311.
|
19. |
Wang L, Li YM, Li L, et al. A systematic review and meta-analysis of the Chinese literature for the treatment of achalasia. World J Gastroenterol, 2008, 14(38): 5900-5906.
|
20. |
Karanicolas PJ, Smith SE, Inculet RI, et al. The cost of laparoscopic myotomy versus pneumatic dilatation for esophageal achalasia. Surg Endosc, 2007, 21(7): 1198-1206.
|
21. |
Kostic S, Johnsson E, Kjellin A, et al. Health economic evaluation of therapeutic strategies in patients with idiopathic achalasia: results of a randomized trial comparing pneumatic dilatation with laparoscopic cardiomyotomy. Surg Endosc, 2007, 21(7): 1184-1189.
|
22. |
Imperiale TF, O’Connor JB, Vaezi MF, et al. A cost-minimization analysis of alternative treatment strategies for achalasia. Am J Gastroenterol, 2000, 95(10): 2737-2745.
|